PetIQ Inc (NASDAQ:PETQ) Director James Nathan Clarke bought 31,031 shares of the business’s stock in a transaction that occurred on Wednesday, May 15th. The stock was acquired at an average cost of $28.12 per share, for a total transaction of $872,591.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
PETQ traded up $0.45 on Friday, hitting $28.60. The company had a trading volume of 701,647 shares, compared to its average volume of 692,784. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.89 and a quick ratio of 1.51. PetIQ Inc has a 52-week low of $17.56 and a 52-week high of $43.93. The firm has a market capitalization of $827.71 million, a PE ratio of 22.88, a price-to-earnings-growth ratio of 1.35 and a beta of 2.04.
PetIQ (NASDAQ:PETQ) last issued its quarterly earnings data on Wednesday, May 8th. The company reported $0.27 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.08 by $0.19. PetIQ had a net margin of 0.51% and a return on equity of 9.47%. The business had revenue of $148.44 million during the quarter, compared to analyst estimates of $139.03 million. Analysts expect that PetIQ Inc will post 0.87 EPS for the current fiscal year.
Several analysts recently issued reports on PETQ shares. Raymond James cut their target price on PetIQ from $42.00 to $39.00 and set an “outperform” rating on the stock in a research note on Monday, March 4th. ValuEngine cut PetIQ from a “buy” rating to a “hold” rating in a research note on Saturday, March 9th. BidaskClub lowered shares of PetIQ from a “strong-buy” rating to a “buy” rating in a report on Saturday, March 9th. Finally, Zacks Investment Research lowered shares of PetIQ from a “hold” rating to a “strong sell” rating in a report on Tuesday, March 5th. One research analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. PetIQ presently has a consensus rating of “Buy” and a consensus price target of $41.67.
ILLEGAL ACTIVITY NOTICE: “Insider Buying: PetIQ Inc (PETQ) Director Purchases 31,031 Shares of Stock” was originally reported by Dakota Financial News and is the property of of Dakota Financial News. If you are viewing this article on another website, it was copied illegally and republished in violation of U.S. & international trademark & copyright laws. The legal version of this article can be accessed at https://dakotafinancialnews.com/2019/05/17/insider-buying-petiq-inc-petq-director-purchases-31031-shares-of-stock.html.
PetIQ Company Profile
PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.
Further Reading: Why do companies issue convertible shares?
Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.